REQUEST A DEMO
Total
USD $0.00
Search more companies

Weng Li Sdn. Bhd. (Malaysia)

Main Activities: Medicinal and Botanical Manufacturing | Pharmacies and Drug Stores
Full name: Weng Li Sdn. Bhd. Profile Updated: February 05, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Weng Li Sdn. Bhd. is an enterprise in Malaysia, with the main office in Kuala Lumpur. It operates in the Medicinal and Botanical Manufacturing industry. It was established on January 05, 1980. The latest financial highlights indicate a net sales revenue increase of 31.33% in 2023. There was a total growth of 3.1% in Weng Li Sdn. Bhd.’s total assets over the same period. The net profit margin of Weng Li Sdn. Bhd. increased by 5.46% in 2023.

Headquarters
No 4 Persiaran 1/118C, Desa Tun Razak Industrial Park Ii
Kuala Lumpur; Federal Territories; Postal Code: 56000

Contact Details: Purchase the Weng Li Sdn. Bhd. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Weng Li Sdn. Bhd. report to view the information.
Registered Capital:
Purchase the Weng Li Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Weng Li Sdn. Bhd. report to view the information.
Incorporation Date:
January 05, 1980
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Weng Li Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
31.33%
Total operating revenue
31.33%
Operating profit (EBIT)
219.48%
EBITDA
37.02%
Net Profit (Loss) for the Period
187.91%
Total assets
3.1%
Total equity
6.08%
Operating Profit Margin (ROS)
8.5%
Net Profit Margin
5.46%
Return on Equity (ROE)
3.46%
Debt to Equity Ratio
0.08%
Quick Ratio
4.28%
Cash Ratio
0.58%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?